Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Idéprövning att använda virulensassocierade gener för utveckling av virulensblockerande läkemedel.
| Reference number | 2003-01822 |
| Coordinator | Creative Antibiotics Sweden AB |
| Funding from Vinnova | SEK 700 000 |
| Project duration | October 2003 - June 2004 |
| Status | Completed |
Last updated 3 February 2021
Reference number 2003-01822
